by Admin | Jun 12, 2017 | Bioethics, News & Opinions, Policy
I just spent a week at Wake Forest University Institute for Regenerative Medicine. I enjoyed the experience of being immersed in all things tissue-regeneration, bio-printing, scaffold development, and, especially, the unique collaboration model they have with private...
by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
